These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 386073

  • 21. Orphan products activities of the National Institutes of Health.
    Schepartz SA.
    Prog Clin Biol Res; 1983; 127():173-86. PubMed ID: 6889399
    [No Abstract] [Full Text] [Related]

  • 22. Clinical trials referral resource. Current clinical trials of bortezomib.
    Wright JJ, Zerivitz K, Schoenfeldt M.
    Oncology (Williston Park); 2003 May; 17(5):677-80, 683-6, 691-2. PubMed ID: 12800794
    [No Abstract] [Full Text] [Related]

  • 23. Technology evaluation: CC49 humanized radioimmunoconjugates, National Cancer Institute.
    Sheikh N.
    Curr Opin Mol Ther; 2003 Aug; 5(4):428-32. PubMed ID: 14513687
    [Abstract] [Full Text] [Related]

  • 24. Clinical research. No lifeline for proposed breast cancer prevention trial.
    Kaiser J.
    Science; 2007 Jun 22; 316(5832):1679. PubMed ID: 17588904
    [No Abstract] [Full Text] [Related]

  • 25. Flasks, fibres and flanks--pre-clinical tumour models for predicting clinical antitumour activity.
    Newell DR.
    Br J Cancer; 2001 May 18; 84(10):1289-90. PubMed ID: 11355935
    [No Abstract] [Full Text] [Related]

  • 26. [Present strategy for new drug development in the USA].
    Shimada Y.
    Gan To Kagaku Ryoho; 1994 Oct 18; 21 Suppl 3():315-24. PubMed ID: 7986110
    [Abstract] [Full Text] [Related]

  • 27. Clinical testing of drugs for cancer in the United States and the Soviet Union.
    Holland JF.
    Natl Cancer Inst Monogr; 1977 Mar 18; (45):261-2. PubMed ID: 927493
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluating promising new treatments for life-threatening disease: implications of the HDC/ABMT experience for treating breast cancer.
    Edwards S.
    Find Brief; 2005 Jan 18; 8(1):1-3. PubMed ID: 15672527
    [No Abstract] [Full Text] [Related]

  • 30. [Antitumor drug screening at the National Cancer Institute, U.S.A].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1987 Oct 18; 14(10):2809-15. PubMed ID: 3310904
    [Abstract] [Full Text] [Related]

  • 31. Molecule of the month. Bortezomib.
    Drug News Perspect; 2003 Jun 18; 16(5):324. PubMed ID: 12942163
    [No Abstract] [Full Text] [Related]

  • 32. A review of the report of the 1966 Cancer Chemotherapy Collaborative Program Review Committee.
    Richardson AP.
    Cancer Treat Rep; 1984 Jan 18; 68(1):340-1. PubMed ID: 6692434
    [No Abstract] [Full Text] [Related]

  • 33. Pharmaceutics. Old regulations, new enforcement.
    Reich SD.
    Cancer Nurs; 1983 Jun 18; 6(3):229-30. PubMed ID: 6344985
    [No Abstract] [Full Text] [Related]

  • 34. Chinese folk treatment reveals power of arsenic to treat cancer, new studies under way.
    Hede K.
    J Natl Cancer Inst; 2007 May 02; 99(9):667-8. PubMed ID: 17470732
    [No Abstract] [Full Text] [Related]

  • 35. Adjuvant chemotherapy of breast cancer. Sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1980 Nov 02; 44(11):721-3. PubMed ID: 7226778
    [No Abstract] [Full Text] [Related]

  • 36. NCI launches an innovative design for a breast cancer clinical trial.
    Whitworth A.
    J Natl Cancer Inst; 2006 Sep 06; 98(17):1178-9. PubMed ID: 16954467
    [No Abstract] [Full Text] [Related]

  • 37. Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
    Young RC, Chabner BA, Hubbard SP, Canellos GP, DeVita VT.
    Natl Cancer Inst Monogr; 1975 Oct 06; 42():145-8. PubMed ID: 825777
    [Abstract] [Full Text] [Related]

  • 38. Interest of the National Cancer Institute in comparative pharmacology.
    Saunders JP.
    Fed Proc; 1967 Oct 06; 26(4):1071-3. PubMed ID: 4961512
    [No Abstract] [Full Text] [Related]

  • 39. Cancer research. Budget pressure puts high-profile study in doubt.
    Marshall E.
    Science; 2007 Mar 16; 315(5818):1477. PubMed ID: 17363634
    [No Abstract] [Full Text] [Related]

  • 40. Oncology's first Phase 0 trial.
    Rowan K.
    J Natl Cancer Inst; 2009 Jul 15; 101(14):978-9. PubMed ID: 19584322
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.